Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Down 59.4% in June

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totaling 1,568 shares, a drop of 59.4% from the May 31st total of 3,862 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 106,636 shares, the short-interest ratio is presently 0.0 days.

Xtant Medical Stock Down 1.2%

Shares of NYSEAMERICAN:XTNT traded down $0.00 during trading on Tuesday, reaching $0.42. 32,008 shares of the company traded hands, compared to its average volume of 83,963. The firm has a fifty day simple moving average of $0.48 and a 200 day simple moving average of $0.57. The company has a quick ratio of 1.64, a current ratio of 3.34 and a debt-to-equity ratio of 0.17. Xtant Medical has a 1-year low of $0.40 and a 1-year high of $0.95. The firm has a market cap of $59.05 million, a P/E ratio of 42.14 and a beta of -0.16.

Xtant Medical (NYSEAMERICAN:XTNT) last posted its quarterly earnings results on Wednesday, May 13th. The medical device company reported ($0.02) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.02). Xtant Medical had a net margin of 1.50% and a return on equity of 3.68%. The business had revenue of $20.88 million for the quarter, compared to the consensus estimate of $20.16 million.

Institutional Investors Weigh In On Xtant Medical

Hedge funds and other institutional investors have recently made changes to their positions in the company. Jane Street Group LLC acquired a new stake in shares of Xtant Medical during the 2nd quarter valued at about $26,000. Tradition Wealth Management LLC acquired a new position in Xtant Medical in the fourth quarter worth approximately $79,000. Wiregrass Investment Management LLC bought a new position in Xtant Medical during the fourth quarter valued at approximately $81,000. Mink Brook Asset Management LLC raised its position in Xtant Medical by 125.8% during the second quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company’s stock valued at $81,000 after acquiring an additional 60,997 shares in the last quarter. Finally, Nano Cap New Millennium Growth Fund L P acquired a new stake in Xtant Medical in the fourth quarter valued at approximately $220,000. 69.33% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

XTNT has been the topic of several recent analyst reports. Craig Hallum reissued a “buy” rating on shares of Xtant Medical in a research report on Wednesday, March 18th. BTIG Research reaffirmed a “buy” rating and set a $1.00 target price on shares of Xtant Medical in a research note on Wednesday, May 13th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Xtant Medical has an average rating of “Buy” and an average target price of $1.00.

Xtant Medical Company Profile

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.